1. Research on CRISPR/system in major cancers and its potential in cancer treatments

   • Z. Liu
   • Z. Liao
   • H. Xiao

   Review Article 15 July 2020 Pages: 425 - 433

   

2. A multidisciplinary consensus on the morphological and functional responses to immunotherapy treatment

   • L. Leon-Mateos
   • M. J. Garcia-Velloso
   • L. Gorospe

   Special Article Open access 04 July 2020 Pages: 434 - 449

   

3. MiR-92 overexpression suppresses immune cell function in ovarian cancer via LATS2/YAP1/PD-L1 pathway

   • S. Feng
   • H. Sun
   • W. Zhu

   Research Article 11 July 2020 Pages: 450 - 458

   

4. Relationship between tumor cell infiltration and 5-aminolevulinic acid fluorescence signals after resection of MR-enhancing lesions and its prognostic significance in glioblastoma

   • J. -K. Kim
   • T. -Y. Jung
   • K. -H. Lee

   Research Article 02 July 2020 Pages: 459 - 467

   

5. miR-143-3p inhibits proliferation and invasion of hepatocellular carcinoma cells by regulating its target gene FGF1

   • J. Peng
   • H. J. Wu
   • R. Zeng

   Research Article 02 July 2020 Pages: 468 - 480

   

6. Patterns of treatment failure in patients with prostate cancer treated with 76–80 Gy radiotherapy to the prostate and seminal vesicles ± hormonotherapy

   • J. López-Torrecilla
   • J. Pastor-Peidro
   • J. Rosello-Ferrando

   Research Article 03 July 2020 Pages: 481 - 490

   

7. miR-144-3p increases radiosensibility of gastric cancer cells by targeting inhibition of ZEB1

   • Z. Y. Gao
   • H. Liu
   • Z. Zhang

   Research Article 01 July 2020 Pages: 491 - 500

   

8. Noncoding RNAs as potential biomarkers for DIPG diagnosis and prognosis: XIST and XIST-210 involvement

   • M. Á. Velázquez-Flores
   • J. M. Rodríguez-Corona
   • R. Ruiz Esparza-Garrido

   Research Article 13 July 2020 Pages: 501 - 513

   

9. CLIC1 knockout inhibits invasion and migration of gastric cancer by upregulating AMOT-p130 expression

   • Y. Qiu
   • Y.-t. Mao
   • J.-l. Liu

   Research Article 13 July 2020 Pages: 514 - 525

   

10. Impact of the extent of axillary surgery in patients with N2–3 disease in the de-escalation era: a propensity score-matched study

    • Y. Kong
    • A. Yang
    • W. Wei

    Research Article 06 July 2020 Pages: 526 - 535

    

11. Bevacizumab in recurrent ovarian cancer: could it be particularly effective in patients with clear cell carcinoma?

    • A. Gallego
    • J. Ramon-Patino
    • A. Redondo

    Research Article 10 July 2020 Pages: 536 - 542

    

12. Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy

    • S. Mollnar
    • P. Pondorfer
    • F. Posch

    Research Article Open access 15 July 2020 Pages: 543 - 553

    

13. Influence of glioblastoma contact with the subventricular zone on survival and recurrence patterns

    • S. Comas
    • E. Luguera
    • S. Villà

    Research Article 29 July 2020 Pages: 554 - 564

    

14. CDC6 is up-regulated and a poor prognostic signature in glioblastoma multiforme

    • H. Zhao
    • X. Zhou
    • X. Li

    Research Article 13 July 2020 Pages: 565 - 571

    

15. Down-regulation of LINC00667 hinders renal tubular epithelial cell apoptosis and fibrosis through miR-34c

    • P. Huang
    • X.-J. Gu
    • J. Wang

    Research Article 23 July 2020 Pages: 572 - 581

    

16. Nivolumab treatment beyond progressive disease in advanced non-small cell lung cancer

    • Takatoshi Enomoto
    • Akihiro Tamiya
    • Shinji Atagi

    Research Article 13 July 2020 Pages: 582 - 590

    

17. SMARCA4 promotes benign skin malignant transformation into melanoma through Adherens junction signal transduction

    • S.-R. Liu
    • X. Yang
    • Y.-Z. Ji

    Research Article 27 July 2020 Pages: 591 - 600

    

18. Paeonol inhibits proliferation and induces cell apoptosis of human T24 and 5637 bladder cancer cells in vitro and in vivo

    • J. J. Zhang
    • L. J. Cai
    • C. H. Han

    Research Article 20 July 2020 Pages: 601 - 611

    

19. MGMT-inhibitor in combination with TGF-βRI inhibitor or CDK 4/6 inhibitor increases temozolomide sensitivity in temozolomide-resistant glioblastoma cells

    • A. Das
    • F. C. Henderson Jr
    • D. Cachia

    Research Article 25 July 2020 Pages: 612 - 619

    

20. The correlation of ¹⁸F-FDG PET/CT metabolic parameters, clinicopathological factors, and prognosis in breast cancer

    • Y.-H. Qu
    • N. Long
    • J. Sun

    Research Article 18 July 2020 Pages: 620 - 627

    

21. Radiotherapy in adult low-grade glioma: nationwide trends in treatment and outcomes

    • R. S. Nunna
    • S. Khalid
    • A. I. Mehta

    Research Article 20 July 2020 Pages: 628 - 637

    

22. Surgery versus stereotactic body radiotherapy for clinical stage I non-small-cell lung cancer: propensity score-matching analysis including the ratio of ground glass nodules

    • N. Tomita
    • K. Okuda
    • Y. Shibamoto

    Research Article 23 July 2020 Pages: 638 - 647

    

23. Identifying a novel 5-gene signature predicting clinical outcomes in acute myeloid leukemia

    • K. Sha
    • Y. Lu
    • L. Chen

    Research Article 10 August 2020 Pages: 648 - 656

    

24. Impact of adjuvant therapy toxicity on quality of life and emotional symptoms in patients with colon cancer: a latent class analysis

    • D. Gomez
    • C. Calderón
    • P. Jimenez-Fonseca

    Brief Research Article 16 July 2020 Pages: 657 - 662

    

25. Correction to: CLIC1 knockout inhibits invasion and migration of gastric cancer by upregulating AMOT-p130 expression

    • Y. Qiu
    • Y.-t. Mao
    • J.-l. Liu

    Correction 16 September 2020 Pages: 663 - 664

    

26. Thanks to reviewers 2020

    Acknowledgement to Reviewers 17 February 2021 Pages: 665 - 668